ARS Pharmaceuticals (SPRY) Property, Plant & Equipment (Net) Growth (1y) (2021 - 2026)
ARS Pharmaceuticals (SPRY) Property, Plant & Equipment (Net) Growth (1y) (2021 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
PP&E (Net) Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
-13.32% |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
17.12% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
-14.18% |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
24.11% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
ARS Pharmaceuticals |
954.24 Mn |
753.27 Mn |
- |
112.56% |
| Date | Value |
|---|
| Mar 31, 2026 |
112.56% |
| Dec 31, 2025 |
131.24% |
| Sep 30, 2025 |
43.42% |
| Jun 30, 2025 |
69.03% |
| Mar 31, 2025 |
74.51% |
| Dec 31, 2024 |
85.71% |
| Sep 30, 2024 |
36.63% |
| Jun 30, 2024 |
7.07% |
| Mar 31, 2024 |
5.48% |
| Dec 31, 2023 |
74.47% |
| Sep 30, 2023 |
4,013.33% |
| Jun 30, 2023 |
-76.10% |
| Mar 31, 2023 |
-75.97% |
| Dec 31, 2022 |
356.94% |
| Sep 30, 2022 |
-99.21% |
| Jun 30, 2022 |
25.25% |
| Mar 31, 2022 |
51.59% |
| Dec 31, 2021 |
-95.55% |
